Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain. [PDF]
Schiuma M +14 more
europepmc +1 more source
Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]
Chavda A +4 more
europepmc +1 more source
Rifampicin-resistant TB in paediatrics: a patient series from a secondary health facility in Northern Malawi. [PDF]
Chitsulo S +7 more
europepmc +1 more source
A scoping review of interventions in childhood tuberculosis prevention and treatment. [PDF]
Rahaman MZ +7 more
europepmc +1 more source
Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis. [PDF]
Gaensbauer J +9 more
europepmc +1 more source
Timing is everything for compassionate use of delamanid [PDF]
openaire +2 more sources
Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study. [PDF]
Qin Y, Chen Y, Cai Q.
europepmc +1 more source
Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report. [PDF]
Klingmüller A +12 more
europepmc +1 more source
A Prospective Cohort Study on the Usage, Safety, and Efficacy of Delamanid in Patients With Pulmonary Multidrug-Resistant Tuberculosis in South Korea. [PDF]
Mok J +7 more
europepmc +1 more source
Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]
Mahmood A +5 more
europepmc +1 more source

